AnPac Bio-Medical Science... (ANPC)

NASDAQ: ANPC · Real-Time Price · USD

4.30

-0.14 (-3.15%)

At close: May 19, 2023, 7:59 PM

AnPac Bio-Medical Science Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2021	Q4 2020	Q2 2020	Q4 2019	Q3 2019	Q4 2018
Period Ending	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Sep 30, 2019	Dec 31, 2018
Net Income	-40.63M	-80.88M	-80.32M	-76.53M	-43.61M	-9.84M
Depreciation & Amortization	1.96M	3.1M	2.52M	3.01M	2.27M	1.24M
Stock-Based Compensation	13.19M	17.76M	19.37M	20.87M	16.13M	1.5M
Other Working Capital	-12.78M	6.95M	9M	9.71M	7.45M	3.03M
Other Non-Cash Items	-29.06M	-5.27M	14.58M	-614K	-2.81M	-4.25M
Deferred Income Tax	-1.27M	6.32M	6.41M	1.86M	-977K	-4.55M
Change in Working Capital	-22.05M	n/a	11.03M	12.33M	5.92M	3.23M
Operating Cash Flow	-77.86M	-58.97M	-26.41M	-34.52M	-18.54M	-8.12M
Capital Expenditures	407K	-2.47M	-3.39M	-2.22M	-1.89M	578K
Cash Acquisitions	-512K	n/a	256K	-44K	-209K	-300K
Purchase of Investments	14.96M	n/a	-7.48M	-7.48M	367K	n/a
Sales Maturities Of Investments	-14.36M	n/a	7.18M	7.18M	-367K	n/a
Other Investing Acitivies	-717K	-16K	334K	4.68M	4.84M	4.93M
Investing Cash Flow	-222K	-3.07M	-3.69M	2.11M	2.75M	5.21M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	15.7M	7.95M	103K	103K	103K	n/a
Dividend Paid	n/a	-103K	-103K	-103K	-103K	n/a
Other Financial Acitivies	34.97M	61.03M	54.79M	25.35M	26.78M	2.2M
Financial Cash Flow	34.97M	60.92M	54.69M	23.04M	24.48M	-2.2M
Net Cash Flow	-41.47M	-1.11M	23.77M	-8.13M	9.72M	-3.05M
Free Cash Flow	-77.45M	-61.43M	-29.79M	-36.74M	-20.43M	-7.54M